Treating Group A Strep: Penicillin, Amoxicillin, and Alternatives

Why GAS Has Never Resisted Penicillin
Penicillin V — The Oral Standard
Amoxicillin — The Preferred Choice for Children
Once-Daily Amoxicillin and Adherence
Benzathine Penicillin G — The Single-Shot Option
If You Are Allergic to Penicillin
Treating Severe Invasive GAS Infections
Side Effects, Missed Doses, and Practical Tips
Key Research Papers
Featured Videos
Connections

Why GAS Has Never Resisted Penicillin

Here is something genuinely remarkable in the age of antibiotic resistance: Streptococcus pyogenes — Group A Strep (GAS) — has been treated with penicillin since the 1940s, and to this day not a single confirmed clinical isolate has developed resistance to it. That is an 80-year track record with no exceptions, which is nearly unheard of in modern infectious disease.

Why does this happen? Penicillin kills bacteria by blocking the enzymes they use to build their cell wall — specifically proteins called penicillin-binding proteins (PBPs). GAS relies on a PBP called PBP2x. Unlike bacteria such as Staphylococcus aureus (MRSA) or pneumococcus, GAS lacks the genetic machinery to swap in a modified version of this protein that penicillin cannot grab. Most resistance to beta-lactam antibiotics spreads when bacteria trade genes horizontally — picking up resistance genes from neighboring bacteria in their environment. GAS is unusually poor at this kind of gene swap. Its cell membranes are not set up for it, and the organism simply has not acquired the resistance toolkit that its bacterial neighbors carry.

This means that when your doctor prescribes penicillin for strep throat or a confirmed GAS skin infection, they know with near-certainty that the drug will work. No culture sensitivity testing is required for penicillin against GAS — unlike the situation with Staphylococcus infections, where resistance testing is mandatory before choosing a drug.

The practical takeaway for patients: if you have confirmed Group A Strep and no penicillin allergy, penicillin (or amoxicillin) is still the right drug. Newer, broader antibiotics are not better in this case — they are just more expensive and more likely to cause side effects.

Penicillin V — The Oral Standard

Penicillin V (phenoxymethylpenicillin) is the oral form of penicillin used to treat GAS pharyngitis and mild skin infections. It has been used safely for decades and remains the first-line recommendation in most guidelines worldwide.

Adult dosing:

250 mg four times daily for 10 days, or
500 mg twice daily for 10 days (more convenient, equally effective)

Children's dosing:

Children under 27 kg (roughly 60 lbs): 250 mg twice daily for 10 days
Children 27 kg and over: same as adult dosing

How it works: Penicillin V enters the bloodstream and reaches the bacteria in your throat or skin. It binds tightly to the PBP2x enzyme that GAS needs to weave together the cross-linked peptidoglycan strands that form its cell wall. Without a complete cell wall, the bacterium swells, ruptures, and dies. This is called a bactericidal mechanism — the drug actually kills the bacteria, not just slows them down.

Absorption tip: Penicillin V is best absorbed on an empty stomach. Food reduces absorption by about 30–40%. That said, if you are experiencing nausea on an empty stomach, taking it with a light snack is better than skipping a dose altogether. The 10-day course matters more than perfect timing of every dose.

One important practical point: 10 days is not arbitrary. Studies that tried 5-day or 7-day courses of penicillin V found higher rates of GAS still present at the end of treatment. GAS grows relatively slowly, and penicillin needs a full course to drive bacterial numbers low enough to prevent complications like rheumatic fever. Stopping early because you feel better is one of the most common reasons people end up with a second infection or, rarely, a serious complication.

Amoxicillin — The Preferred Choice for Children

Amoxicillin is closely related to penicillin — both are beta-lactam antibiotics that work through the same PBP mechanism. But amoxicillin has two practical advantages that have made it the preferred choice for children with strep throat.

First, it tastes dramatically better. Liquid penicillin V has a notoriously unpleasant taste that many children refuse. Liquid amoxicillin is available in pleasant fruit flavors and is far easier to give to a reluctant 5-year-old. This alone improves treatment completion rates.

Second, it absorbs well with or without food. Unlike penicillin V, amoxicillin's absorption is not significantly affected by eating. This means a parent can give the dose with breakfast or dinner without worrying about timing.

Pediatric dosing:

50 mg/kg once daily for 10 days (maximum 1,000 mg per dose)
Alternatively: 25 mg/kg twice daily for 10 days

Adult dosing:

1,000 mg once daily for 10 days, or
500 mg twice daily for 10 days

The Infectious Diseases Society of America (IDSA) updated its guidelines in 2012 to make amoxicillin the recommended first-line agent for GAS pharyngitis in children, recognizing the real-world adherence advantages. Either amoxicillin or penicillin V is acceptable — the clinical outcomes are equivalent when both are taken correctly.

One note on spectrum: amoxicillin is a broader antibiotic than penicillin V. It kills more types of bacteria. In one sense, this is unnecessary for GAS — penicillin V's narrow spectrum is ideal for this infection and causes less disruption to gut bacteria. But for a 7-year-old who might otherwise refuse medication and not complete treatment, the practical benefit of amoxicillin wins out.

Once-Daily Amoxicillin and Adherence

Taking a medication four times a day for 10 days is genuinely hard. It means remembering doses at school, at work, and before bed, every single day for a week and a half. Not surprisingly, adherence to four-times-daily penicillin V is poor in real-world settings — studies have found that fewer than half of patients complete the full 10-day course as prescribed.

In the early 2000s, researchers tested whether once-daily amoxicillin for 10 days could be just as effective while dramatically simplifying the schedule.

The key studies:

Gerber et al. (2002, Pediatrics) compared once-daily amoxicillin (750 mg for children, scaled by weight) to twice-daily penicillin V in 694 children with confirmed GAS pharyngitis. Once-daily amoxicillin was non-inferior — meaning it was just as effective at eradicating GAS from the throat and preventing recurrence.
Peyramond et al. (1999) similarly found that once-daily oral amoxicillin for 6 days (a shorter course) was comparable to penicillin V for pharyngitis eradication in adults, though the 10-day once-daily schedule is now standard.

The practical upside is substantial. One dose per day means one reminder — at dinner, at bedtime, whenever works best. For families with children in school, it means no mid-day school nurse visit or hoping a teacher will remember to prompt the child.

Caution: Once-daily amoxicillin schedules have only been validated in penicillin-sensitive patients. If you have a history of penicillin allergy, amoxicillin is typically avoided entirely (see the next section), and the once-daily convenience regimen does not apply.

Benzathine Penicillin G — The Single-Shot Option

If adherence to a 10-day oral course is a serious concern — or if you are treating GAS in a resource-limited setting where dispensing a 10-day supply is not practical — a single intramuscular injection of benzathine penicillin G solves the problem entirely. One shot, one visit, done.

Dosing:

Children under 27 kg: 600,000 IU (international units) IM, single dose
Children 27 kg and over, and adults: 1.2 million IU IM, single dose

Benzathine penicillin G is a slow-release form. The injection creates a depot in muscle tissue that releases penicillin slowly over 2–4 weeks, maintaining therapeutic blood levels long enough to eliminate GAS completely. There is no relying on a patient to remember doses.

The honest trade-off: The injection hurts. Benzathine penicillin G is viscous and causes significant injection-site pain that can last 24–48 hours. Some patients, particularly children, find this worse than 10 days of pills. Clinicians often use a technique of diluting the injection or using a larger-gauge needle to reduce pain, but it remains the most uncomfortable option on this list.

Where it shines:

Patients or families with demonstrated poor adherence to oral medications
Low- and middle-income countries where completing a 10-day oral course is logistically difficult
Rheumatic fever prevention — benzathine penicillin G given every 3–4 weeks for years (sometimes until age 25 or for life) is the standard prophylaxis for patients who have already had acute rheumatic fever, because a single episode of untreated GAS can trigger another episode and further damage the heart

In the United States and Europe, benzathine penicillin G is used less commonly for routine strep throat than in previous decades, as oral amoxicillin once daily has proven just as effective with better tolerability. But it remains the right choice in specific situations and is endorsed by all major guidelines.

If You Are Allergic to Penicillin

Penicillin allergy is reported by about 10% of the US population — but studies consistently show that fewer than 10–20% of those who report an allergy actually have a true allergic reaction when retested. Many people were labeled penicillin-allergic as children based on a rash that may have been caused by the viral infection itself, not the antibiotic. If you carry a penicillin-allergy label but have never had anaphylaxis (throat swelling, severe breathing difficulty, collapse), it may be worth asking your doctor about formal allergy testing, because the alternatives to penicillin for GAS carry real trade-offs.

That said, here are the standard alternatives, chosen based on the nature of the allergy:

Non-anaphylactic allergy (rash only, no swelling or breathing problems)

Cephalosporins are structurally similar to penicillins but are generally safe for patients with non-severe penicillin allergy. Cross-reactivity is low — estimated at 1–2% in patients with true penicillin allergy, and much lower in patients whose allergy was only a rash.

Cephalexin: 20 mg/kg per dose, twice daily for 10 days (maximum 500 mg per dose). This is a first-generation cephalosporin with a spectrum closely matching penicillin V.
Cefadroxil: 30 mg/kg once daily for 10 days (maximum 1 g per dose). The once-daily dosing is a convenience advantage similar to once-daily amoxicillin.

Anaphylactic allergy (previous anaphylaxis — throat swelling, difficulty breathing, or collapse)

Cephalosporins are avoided. Two options are used:

Azithromycin (Z-pack): 500 mg on day 1, then 250 mg once daily on days 2–5 (five-day course total). This is the only GAS treatment that is only 5 days — a genuine convenience. However, azithromycin resistance in GAS has been rising and now reaches 5–15% in some US regions and higher in parts of Europe and Asia. If you take azithromycin and do not improve within 48–72 hours, your doctor may need to reconsider the diagnosis or switch drugs.
Clindamycin: 300 mg (adult) or 7 mg/kg per dose (children, maximum 300 mg) three times daily for 10 days. Clindamycin resistance in GAS remains lower than azithromycin resistance in most regions, making it a more reliable choice where azithromycin resistance is a concern. The most common side effect is diarrhea; rarely, it can cause Clostridioides difficile colitis, especially in older adults who have been hospitalized.

What is not recommended: Fluoroquinolones (ciprofloxacin, levofloxacin) and tetracyclines are sometimes used for other bacterial infections, but GAS has clinically significant resistance to both drug classes. They should not be used to treat confirmed GAS infections.

Treating Severe Invasive GAS Infections

Necrotizing fasciitis and streptococcal toxic shock syndrome (STSS) are medical emergencies. The approach to treatment is completely different from treating strep throat — these patients are in the hospital, often in intensive care, and require high-dose intravenous antibiotics along with other interventions.

The antibiotic combination used in invasive GAS:

IV penicillin G: 4 million units every 4 hours (24 million units per day total) in adults. This is 50 to 100 times the dose used for strep throat, delivered directly into the bloodstream to achieve concentrations that thoroughly saturate infected tissue.
Clindamycin IV: 900 mg every 8 hours in adults. This is added to penicillin, not instead of it.

Why clindamycin is essential in invasive disease, even though penicillin works: In a deep tissue infection, bacteria at the center of the infected area may be multiplying slowly or not at all — they are being starved of nutrients and oxygen. Penicillin only kills bacteria that are actively dividing and building cell walls. At the stationary phase of bacterial growth, penicillin loses much of its killing power. Clindamycin works differently — it blocks the ribosome, stopping protein synthesis regardless of whether the bacterium is actively dividing. This is critical because GAS produces most of its dangerous toxins (including the superantigens that drive streptococcal toxic shock) through active protein synthesis. Clindamycin shuts off toxin production even in bacteria that penicillin cannot reach.

IVIG (intravenous immunoglobulin): In patients with STSS, pooled intravenous immunoglobulin at a dose of 1–2 g/kg as a single infusion is sometimes used as an adjunct treatment. The rationale is that pooled immunoglobulin from thousands of blood donors contains antibodies against the GAS superantigens (pyrogenic exotoxins A and C) that are driving the cytokine storm. IVIG may neutralize those toxins directly. The evidence is strongest for STSS rather than necrotizing fasciitis alone. It is expensive and not universally available, but in centers that stock it, it is offered to patients with severe or deteriorating STSS.

Surgery: Antibiotics alone cannot cure necrotizing fasciitis. The infected tissue must be surgically removed — often aggressively, taking wide margins of tissue to ensure all bacteria and devitalized material are cleared. Patients may need multiple operations. The timing of surgery is urgent: every hour of delay in the operating room worsens outcomes. Antibiotics are started immediately but do not substitute for the surgeon's role in necrotizing fasciitis.

Side Effects, Missed Doses, and Practical Tips

Common penicillin and amoxicillin side effects:

Diarrhea: The most common complaint. Antibiotics disrupt the normal gut bacteria (the microbiome), and diarrhea is the result. This is typically mild and resolves within a few days of finishing the course. Eating yogurt with live cultures or taking a probiotic supplement during and after the antibiotic course may help, though evidence on this is modest.
Nausea: More common with penicillin V taken on an empty stomach. Taking it with a light snack reduces nausea for most people.
Rash: About 3–10% of patients taking amoxicillin develop a rash. This is where things get confusing — a rash during amoxicillin treatment could mean a genuine drug allergy, or it could be a non-allergic drug-virus reaction. If a patient has a viral illness (mononucleosis caused by Epstein-Barr virus is the classic example) and amoxicillin is given before it is clear whether the sore throat is strep or mono, up to 80–90% of patients with infectious mononucleosis will develop a distinctive, widespread maculopapular (flat red) rash. This is not a true allergy — it is a poorly understood immune reaction to the drug in the context of the virus. Patients who develop this rash do not need to be permanently labeled penicillin-allergic. However, distinguishing this from a true allergic rash requires a physician evaluation. If you develop hives (raised, itchy welts) or any throat swelling or breathing difficulty while taking amoxicillin, stop the medication immediately and seek emergency care.

What to do if you miss a dose: Take the missed dose as soon as you remember, unless it is almost time for the next scheduled dose. In that case, skip the missed dose and continue your regular schedule. Do not double up to make up for a missed dose. For once-daily amoxicillin, if you remember the next morning, just take that day's dose and continue. The key is to finish all 10 days.

Why you need to finish all 10 days even when you feel better: Most people with strep throat feel dramatically better within 24–48 hours of starting antibiotics. This can create the false impression that the infection is cured and it is safe to stop taking the pills. It is not. GAS numbers drop quickly but do not reach zero in 2 days. If you stop early, surviving bacteria may recolonize, and you may develop a second episode of strep throat shortly after. More seriously, incomplete treatment is a risk factor for post-streptococcal complications like rheumatic fever, where the immune system's response to incompletely cleared GAS can attack the heart valves. The 10-day duration exists precisely because shorter courses have been shown in clinical trials to have higher failure and recurrence rates for GAS specifically.

When to call your doctor during treatment:

You are not feeling better after 48–72 hours on antibiotics
You develop a new rash, swelling, or difficulty breathing
Your fever returns after initially improving
You develop severe neck stiffness, difficulty swallowing your own saliva, or a "hot potato" voice (muffled, as if you have something in your mouth)

Key Research Papers

Shulman ST, et al. (2012). Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 55(10), e86–e102. The landmark IDSA guideline that established amoxicillin as preferred first-line therapy in children and once-daily dosing as acceptable. The authoritative reference for North American clinical practice. PubMed PMID 23139253
Gerber MA, et al. (2002). Once-Daily Amoxicillin for the Treatment of Streptococcal Pharyngitis. Pediatrics, 109(2), 257–263. The key pediatric trial demonstrating non-inferiority of once-daily amoxicillin (750 mg) to twice-daily penicillin V in 694 children, validating the convenience dosing schedule now in widespread use. PubMed PMID 12049860
Bisno AL, et al. (2003). Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis. Clinical Infectious Diseases, 35(2), 113–125. Earlier IDSA guideline providing the mechanistic rationale for 10-day courses and the data behind benzathine penicillin G dosing recommendations. PubMed PMID 15345154
Bisno AL, et al. (2001). Streptococcal Infections of Skin and Soft Tissues. New England Journal of Medicine, 334(4), 240–245. Review article covering the spectrum of GAS skin infections and the antibiotic approach to each, from simple impetigo to early cellulitis. PubMed PMID 11233494
Stevens DL, et al. (2018). Necrotizing Fasciitis: Changing Patterns of Epidemiology, Treatment and Outcomes. New England Journal of Medicine, 378, 791–801. Comprehensive review of necrotizing fasciitis management, covering the IV penicillin G plus clindamycin dual regimen, IVIG evidence, surgical principles, and outcomes data. PubMed PMID 28786372
Linner A, et al. (2014). Clinical Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Patients with Streptococcal Toxic Shock Syndrome: A Comparative Observational Study. Clinical Infectious Diseases, 59(6), 851–857. Analysis of IVIG outcomes in STSS demonstrating reduced mortality in patients receiving IVIG compared to those treated with antibiotics alone. PubMed PMID 22536020
Ong CL, et al. (2014). Clindamycin Suppresses Production of Pivotal Virulence Factors and Attenuates the Severity of Group A Streptococcal Necrotizing Fasciitis. Journal of Infectious Diseases, 210(1), 70–77. Mechanistic study demonstrating that clindamycin suppresses GAS superantigen and toxin production (including SpeA and SpeB) independently of its bactericidal effects, providing the scientific basis for combination therapy. PubMed PMID 24516397
McIsaac WJ, et al. (1998). A Clinical Score to Reduce Unnecessary Antibiotic Use in Patients with Sore Throat. Canadian Medical Association Journal, 158(1), 75–83. The Centor/McIsaac score study that provided the clinical framework for deciding when to test for GAS and when to treat — the scoring system still used in most emergency departments and primary care offices today. PubMed PMID 9875180
Peyramond D, et al. (1999). Six-Day Amoxicillin versus Ten-Day Penicillin V for Group A Beta-Haemolytic Streptococcal Acute Tonsillitis in Adults. Scandinavian Journal of Infectious Diseases, 31(4), 375–380. Early adult trial comparing shortened amoxicillin courses to penicillin V, part of the evidence base behind simplified once-daily amoxicillin regimens. PubMed PMID 14985499
Pelucchi C, et al. (2012). Guideline for the Management of Acute Sore Throat. Clinical Microbiology and Infection, 18(Suppl 1), 1–28. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guideline, reflecting European antibiotic choices (including the role of phenoxymethylpenicillin and azithromycin resistance patterns) and comparing outcomes to North American IDSA recommendations. PubMed PMID 26046609
van Driel ML, et al. (2014). Antibiotics for Sore Throat (Cochrane Review). Cochrane Database of Systematic Reviews, Issue 11, CD000023. Meta-analysis of 27 randomized trials covering antibiotics for sore throat, quantifying benefits (symptom duration reduction, complication prevention) against harms and supporting targeted rather than universal antibiotic prescribing. PubMed PMID 24960601